Stocks
AstraZeneca PLC (AZN) EBITDA margin US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 21.0% | 20.5% | 29.3% | 28.6% | 33.8% | 33.9% | ||
| Changes by years, y/y, % | +7pp | -1pp | +9pp | -1pp | +5pp | +3.5% | |||
AstraZeneca PLC. EBITDA margin, %
AstraZeneca PLC. EBITDA margin, changes, pp
AstraZeneca PLC (AZN) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 37.1% | 34.3% | 34.4% | 29.7% | 37.1% | 33.9% | |
| Changes by years, y/y, % | +2pp | +2pp | +4pp | +11pp | +0pp | |||
| Changes by quarters, q/q, % | +18pp | -3pp | +0pp | -5pp | +7pp | |||
